DMAC

DIAMEDICA THERAPEUTICS INC

DMAC·25253X207·US·Common Stock·Healthcare - Biotechnology-13D/G

DMAC (DIAMEDICA THERAPEUTICS INC) is held by 64 institutional investors as of Q1 2026. Largest holders: COOPERMAN LEON G ($13.7M), BlackRock, Inc. ($12.6M), MILLENNIUM MANAGEMENT LLC ($6.3M). Net institutional sentiment: Mixed.

64
Holders
Avg rating(16 Elite)
$65.1M
Total Value
52% (73)
Fund Consensus
34 buying - 31 selling
DMACSmart Money Verdict
View all
Held by 64 funds
16 elite
Who's Trading
ActivistDLDialectic Life Sciences SPV LLC0.0%Feb 17, 2026
ActivistCLCooperman Leon G.6.6%Feb 17, 2026
ActivistTATRILL AB16.9%Feb 6, 2026
InsiderSJSTAHLBERG JANBuy $627KNov 25, 2025
InsiderSJSTAHLBERG JANBuy $318KNov 24, 2025
InsiderSJSTAHLBERG JANBuy $1.5MNov 21, 2025
InsiderSJSTAHLBERG JANBuy $951KNov 20, 2025
InsiderSJSTAHLBERG JANBuy $1.7MNov 19, 2025
InsiderSJSTAHLBERG JANBuy $1.2MNov 18, 2025
InsiderSJSTAHLBERG JANBuy $1.2MNov 17, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
2M$13.7M0.4%+49.47%
0
Decreased
1.9M(-2.4%)$12.6M0.0%+47.42%
0
Increased
935,592(+21.7%)$6.3M0.0%+8.75%
33
Increased
780,516(+2.1%)$5.3M0.0%+58.79%
28
Increased
644,211(+2.6%)$4.4M0.0%+29.37%
27
Increased
455,000(+12.3%)$3.1M0.0%+119.80%
30
Increased
338,526(+4.0%)$2.3M0.0%+68.22%
27
New
333,456$2.3M0.0%-0.52%
36
Increased
319,675(+29.4%)$2.2M0.0%+29.31%
33
Increased
226,050(+14.7%)$1.5M0.0%+66.90%
29
New
203,459$1.4M0.0%-0.52%
35
New
187,724$1.3M0.0%-0.52%
35
Increased
145,724(+31.6%)$986,5510.0%+3.29%
32
Increased
111,320(+100.0%)$753,6360.0%-2.66%
40
Decreased
111,079(-8.2%)$752,0010.0%+30.53%
0
Decreased
105,420(-80.8%)$713,6940.0%+38.41%
0
Decreased
88,421(-8.7%)$598,6100.0%+70.59%
0
Decreased
79,110(-28.8%)$535,5740.0%+21.10%
0
New
60,011$406,2740.0%-0.52%
33
Decreased
59,288(-54.2%)$401,3800.0%+8.63%
0

Showing 1-20 of 73

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used